SALT LAKE CITY, March 31, 2015 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), has announced that Vice President of Product Development Nathalie Chevreau, PhD is presenting a poster abstract at the Experimental Biology 2015 Boston meeting. The poster highlights a portion of the findings from clinical research being conducted by LifeVantage on its Canine Health product, a Nrf2 Synergizer for dogs.
The findings from the research show a decrease in oxidative stress in dogs that have taken Canine Health over a period of 60 days. The studies also demonstrate improved physical performance in the dogs taking Canine Health. These improvements include greater mobility, faster running times, decreased stiffness, and increased energy levels when compared to dogs taking a placebo.
"Experimental Biology is the largest gathering of lifestyle scientists in the world, so we are honored that LifeVantage is invited to present our research to such a prestigious audience," said LifeVantage Chief Science Officer, Shawn Talbott, PhD. "These results demonstrate the ability of Canine Health to reduce cellular stress and improve the quality of life in older dogs- which is something that all 'dog parents' want for their best friends."
Experimental Biology is an annual meeting comprised of more than 14,000 research scientists whose fields of study include anatomy, physiology, pathology, biochemistry, nutrition, and pharmacology.
About LifeVantage Corporation
LifeVantage Corporation (Nasdaq:LFVN), is a science based network marketing company dedicated to visionary science that looks to transform health, wellness and anti-aging internally and externally at the cellular level. The company is the maker of Protandim®, the Nrf2 Synergizer® patented dietary supplement, the TrueScience™ Anti-Aging Skin Care Regimen, Canine Health, and the AXIO™ energy product line. LifeVantage was founded in 2003 and is headquartered in Salt Lake City, Utah.